Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium

Ireland - English - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - levothyroxine sodium anhydrous ep - tablet - levothyroxine sodium

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 137 microgram - tablet - excipient ingredients: colloidal anhydrous silica; purified talc; microcrystalline cellulose; magnesium stearate; maize starch - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 125 microgram - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; purified talc; maize starch; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 100 microgram - tablet - excipient ingredients: magnesium stearate; maize starch; purified talc; colloidal anhydrous silica; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 75 microgram - tablet - excipient ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; purified talc; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet - excipient ingredients: colloidal anhydrous silica; maize starch; purified talc; microcrystalline cellulose; magnesium stearate - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet - excipient ingredients: purified talc; colloidal anhydrous silica; magnesium stearate; maize starch; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 25 microgram - tablet - excipient ingredients: purified talc; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.